Cardiovascular disease. Atherosclerotic heart disease
Conditions
Interventions
Intervention 1: This study included 27 persons (control group) who did not use angiotensin inhibitors to control blood pressure. They used drugs such as 20 mg Metoral four times a day and 50 mg Atenol
Treatment - Drugs
This study included 27 persons (control group) who did not use angiotensin inhibitors to control blood pressure. They used drugs such as 20 mg Metoral four times a day and 50 mg Atenolol twice a day i
The other group included 27 persons (experimental group) who received the angiotensin inhibitor with the dosage of 25 mg twice a day and underwent surgery by general anesthesia. The experiment group p
Sponsors
Vice Deputy Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: the inclusion criteria: involvement of the coronary arteries; the blockage of two to three major vessels; history of high blood pressure; hyperlipidemia; the use of angiotensin inhibitor drugs; none use of angiotensin inhibitor drugs The exclusion criteria:renal failure; hepatic failure; pregnancy; record of angioedema; allergy to angiotensin inhibitor
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood-Oxygen Saturaion. Timepoint: Pre Operation, Operation, Post Operation. Method of measurement: Pulse Oximeter.;Blood pressure. Timepoint: pre Operation,Operation,Post operation. Method of measurement: Pressure Measurement. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtarian Mansooreh
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed